A trial of chemoprophylaxis of natural influenza infection with U.K. 2371
AUTOR(ES)
Stark, J. E.
RESUMO
In a five-week double-blind trial, 132 young adult volunteers received U.K. 2371, a synthetic isoquinoline derivative which had previously been shown to protect volunteers against challenge with certain influenza viruses. A comparable group of 130 volunteers received placebo. There was little difference between the groups in number or severity of acute respiratory illnesses during the trial or in the number of proven infections with influenza A2/Hong Kong/1968 virus. Tablet counts were carried out and single doses of isoniazid were used as a marker to confirm that the lack of prophylaxis was not the result of the failure of volunteers to ingest the tablets.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=472206Documentos Relacionados
- Custom and Practice in Medical Care: A Comparative Study of Two Hospitals in Arbroath, Scotland, U.K. and Waterville, Maine, U.S.A.
- Treatment-Refractory Depression in the Elderly: An Audit of Primary Care Referrals to Psychiatric Services in Swindon, U.K.
- Does routine child health surveillance contribute to the early detection of children with pervasive developmental disorders? – An epidemiological study in Kent, U.K.
- Evidence for Linkage of Stature to Chromosome 3p26 in a Large U.K. Family Data Set Ascertained for Type 2 Diabetes
- A Genomewide Scan for Loci Predisposing to Type 2 Diabetes in a U.K. Population (The Diabetes UK Warren 2 Repository): Analysis of 573 Pedigrees Provides Independent Replication of a Susceptibility Locus on Chromosome 1q